Cite
Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.
MLA
Shalaby, Asem A. E., et al. “Analysis of the Fibroblastic Growth Factor Receptor-RAS/RAF/MEK/ERK-ETS2/Brachyury Signalling Pathway in Chordomas.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 22, no. 8, Aug. 2009, pp. 996–1005. EBSCOhost, https://doi.org/10.1038/modpathol.2009.63.
APA
Shalaby, A. A. E., Presneau, N., Idowu, B. D., Thompson, L., Briggs, T. R. W., Tirabosco, R., Diss, T. C., & Flanagan, A. M. (2009). Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, 22(8), 996–1005. https://doi.org/10.1038/modpathol.2009.63
Chicago
Shalaby, Asem A E, Nadege Presneau, Bernadine D Idowu, Lisa Thompson, Timothy R W Briggs, Roberto Tirabosco, Timothy C Diss, and Adrienne M Flanagan. 2009. “Analysis of the Fibroblastic Growth Factor Receptor-RAS/RAF/MEK/ERK-ETS2/Brachyury Signalling Pathway in Chordomas.” Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 22 (8): 996–1005. doi:10.1038/modpathol.2009.63.